These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 11772146)

  • 21. [Analgesic abuse and psychiatric comorbidity in headache patients].
    Radat F; Irachabal S; Swendsen J; Henry P
    Encephale; 2002; 28(5 Pt 1):466-71. PubMed ID: 12386550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication Overuse Headache Due to Butalbital, Acetaminophen, and Caffeine Tablets.
    Feeney R
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):148-9. PubMed ID: 27159186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine and headache: specific remarks.
    Espinosa Jovel CA; Sobrino Mejía FE
    Neurologia; 2017; 32(6):394-398. PubMed ID: 25728949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of the analgesic effect of Dikalm and Saridon in headaches of various causes].
    Jovicić A; Raicević R; Bosković B
    Vojnosanit Pregl; 1998; 55(3):265-9. PubMed ID: 9720441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphometric changes over the whole brain in caffeine-containing combination-analgesic-overuse headache.
    Chen X; Chen Z; Dong Z; Liu M; Yu S
    Mol Pain; 2018; 14():1744806918778641. PubMed ID: 29877133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features of withdrawal headache following overuse of triptans and other headache drugs.
    Mauskop A
    Neurology; 2002 May; 58(9):1443; author reply 1443-4. PubMed ID: 12011309
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and tolerability of combined dipyrone, isometheptene and caffeine in the treatment of mild-to-moderate primary headache episodes.
    de Souza Carvalho D; Barea LM; Kowacs PA; Fragoso YD
    Expert Rev Neurother; 2012 Feb; 12(2):159-67. PubMed ID: 22288671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeine as a promoter of analgesic-associated nephropathy--where is the evidence?
    Fox JM; Siebers U
    Fundam Clin Pharmacol; 2003 Jun; 17(3):377-92. PubMed ID: 12803578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management.
    Smith TR; Stoneman J
    Drugs; 2004; 64(22):2503-14. PubMed ID: 15516151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A risk-benefit assessment of paracetamol (acetaminophen) combined with caffeine.
    Palmer H; Graham G; Williams K; Day R
    Pain Med; 2010 Jun; 11(6):951-65. PubMed ID: 20624245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analgesic nephropathy].
    Pintér I; Nagy J
    Orv Hetil; 1998 Nov; 139(47):2839-43. PubMed ID: 9846064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant analgesics in neuropathic pain.
    Kong VK; Irwin MG
    Eur J Anaesthesiol; 2009 Feb; 26(2):96-100. PubMed ID: 19142081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treating pain after dental surgery: a randomised, controlled, double-blind trial to assess a new formulation of paracetamol, opium powder and caffeine versus tramadol or placebo].
    Borel JF; Deschaumes C; Devoize L; Huard C; Orliaguet T; Dubray C; Baudet-Pommel M; Dallel R
    Presse Med; 2010 May; 39(5):e103-11. PubMed ID: 20080382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genesis of analgesic nephropathy in the United Kingdom.
    Murray RM
    Kidney Int; 1978 Jan; 13(1):50-7. PubMed ID: 713268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication-overuse headache in children: is initial preventive therapy necessary?
    Kossoff EH; Mankad DN
    J Child Neurol; 2006 Jan; 21(1):45-8. PubMed ID: 16551452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of analgesic nephropathy in Belgium.
    Vanherweghem JL; Even-Adin D
    Clin Nephrol; 1982 Mar; 17(3):129-33. PubMed ID: 7067174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic daily headache: identification of factors associated with induction and transformation.
    Bigal ME; Sheftell FD; Rapoport AM; Tepper SJ; Lipton RB
    Headache; 2002; 42(7):575-81. PubMed ID: 12482208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. It may be the caffeine in Extra Strength Excedrin that is effective for migraine.
    Strong FC
    J Pharm Pharmacol; 1997 Dec; 49(12):1260. PubMed ID: 9466355
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: The clinical course of patients with analgesic nephropathy.
    Gault MH
    Can Med Assoc J; 1975 Aug; 113(3):204-7. PubMed ID: 1139519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analgesic rebound headache in clinical practice: data from a physician survey.
    Rapoport A; Stang P; Gutterman DL; Cady R; Markley H; Weeks R; Saiers J; Fox AW
    Headache; 1996 Jan; 36(1):14-9. PubMed ID: 8666530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.